Top Big Data Companies With Best Stability & Growth (2,109)

Strong Revenue Growth: Multiple consecutive quarters of revenue growth and a multi‑quarter streak indicate renewed momentum, with management highlighting gains in visit share and engagement. Feedback suggests premium offerings and expansion into seller, new‑construction, and rentals are lifting monetization.

Strong Market Position & Advantage: Company updates and trade coverage describe a clear second‑place portal position with rising visit share and leading visits per unique user. These signals point to durable audience scale and high‑intent engagement.

Strategic Partnerships: Recent collaborations—such as the pre‑market listings tie‑up with Zillow and rental syndication—expand content reach and potential lead flow. Feedback suggests these partnerships can enhance traffic quality and advertiser appeal.

Strong Revenue Growth: Recent disclosures show rising total revenue and accelerating Galleri test volumes year over year, with both full‑year 2025 and early 2026 reporting continued momentum. Quarterly updates point to sustained double‑digit growth across revenue and volumes.

Strategic Partnerships: Announcements detail deeper channel integrations and access, including Epic EHR ordering, Quest connectivity, and collaborations with health systems, employers, and digital‑health platforms. International arrangements, such as a Samsung collaboration and a Canada launch, further extend reach.

Investor Backing & Capital Strength: The company secured additional financing in late 2025 and reports a cash position described as providing a multi‑year runway. Public company status post‑spin‑off offers direct access to capital markets to fund commercialization and regulatory efforts.

Strong Revenue Growth: Full-year revenue increased and the latest quarter also showed year-over-year gains, with organic growth remaining positive. This indicates the top line is expanding even as costs and volumes begin to normalize.

Healthy Cash Flow: Management guides to substantial free cash flow for the year ahead and continued share repurchases were reported. These signals suggest ongoing capacity to fund investment and capital returns.

Market Expansion: Latin America and AMEA delivered solid organic growth in the latest quarter, with pricing as the primary driver. Broad-based regional contributions supported overall revenue momentum.

Product Line Growth: Company disclosures highlight growth within specific products and brands, including gains in the Products segment and increased traffic and revenue at MapQuest. These pockets of momentum on Startpage, MapQuest, and other owned properties are cited as not yet offsetting declines but do show segment-level expansion.

Cost & Operational Efficiency: Management emphasizes improved adjusted gross profit, adjusted EBITDA, and margin expansion tied to cost actions and mix. Disclosures suggest efficiency initiatives and reduced lower‑return marketing spend have improved non‑GAAP profitability even as revenue fell.

Future-Ready Strategy: Leadership describes a strategic reset narrowing focus to the intersection of AI and consumer intent and integrating AI/ML into the RAMP platform. Company materials indicate plans to expand platform capabilities and automation to drive efficiency and longer‑term scalability.

Strong Revenue Growth: Clearing-fee revenue increased in 2025 alongside higher cleared volumes, with momentum continuing into early 2026. Financial updates also indicate higher shareholders’ equity, reflecting an expanded operating base.

Profitability: Net income rose in 2025 as activity scaled, signaling improved earnings power. The step-up in volume and fees suggests greater financial flexibility to fund risk management and technology initiatives.

Market Expansion: OCC added clearing for MIAX Futures Exchange in May 2026, increasing the number of venues it serves. Broader coverage across exchanges and trading platforms supports growth in throughput and ecosystem reach.

Investor Backing & Capital Strength: The company emerged from stealth in June 2023 with a $45M Series A led by NEA and Bain Capital Ventures, and leadership has stated a strong balance sheet to fund growth. These factors indicate resources to pursue expansion among petabyte-scale S3/GCS customers.

Strategic Partnerships: Granica joined Google Cloud Partner Advantage and listed offerings on AWS and Google Cloud Marketplaces. Such placements are described as easing procurement and helping joint customers accelerate AI initiatives.

Product Line Growth: Offerings expanded from Crunch (data reduction) to include Screen (data safety/privacy) and Chronicle/Signal, reflecting a broader platform surface area than at launch. Public materials cite integrations across lakehouse engines and table formats aligned to enterprise AI/analytics.

Strategic Partnerships: Recent partnerships with Comcast Advertising’s Outcomes+, Vevo (preferred partner), and DAX US expand DISQO’s distribution across TV/CTV and digital audio. These relationships indicate growing traction with major media owners and platforms.

Product Line Growth: The company has expanded its cross‑media measurement stack since launching Outcomes Lift in 2022, including a 2025 free self‑serve Brand Lift product for media companies. Cookieless, identity‑based offerings and unified benchmarks enhance the breadth of its measurement capabilities.

Market Expansion: Claims of 500+ brands, 150+ agency/media partners, and a 2.3M+ opted‑in U.S. audience point to a broadening commercial and data footprint. Integration across traditional/streaming TV, social, and audio channels reflects increasing cross‑channel coverage.

Investor Backing & Capital Strength: Evidence shows a $372M Series D in June 2024 led by a16z with Sanofi participation, one of the larger biotech financings that year. The capital is framed as fuel for acquiring or in-licensing assets and expanding AI capabilities, signaling strong investor confidence.

Strategic Partnerships: A three‑way collaboration with Sanofi and OpenAI announced in May 2024 to build AI software for drug development highlights high‑profile external alignment. Additional partnered activity, such as the 2025 Sanofi deal for gusacitinib, illustrates the company’s model in practice.

Product Line Growth: Since 2025 the portfolio expanded via in‑licensing and asset‑centric subsidiaries, including an anti‑CD226 mAb (IMIDomics), a miR‑124 activator (Kenmare Bio), and ex‑China rights to a CNS‑penetrant TYK2 inhibitor from Lynk. A planned Phase 1 start in H1 2026 underscores near‑term pipeline progression.

Strong Revenue Growth: Revenue is expanding at a double‑digit pace, with recent quarterly results beating expectations and management guiding continued growth for the year. Feedback suggests this builds on a multi‑year rebound and broad momentum across U.S. and international segments.

Market Expansion: Growth is broad‑based across key segments and regions, with U.S. Financial Services accelerating and an expanded footprint in Mexico via a new majority stake. Feedback suggests strategic acquisitions have supported the raised full‑year outlook.

Future-Ready Strategy: Management is investing to drive ongoing expansion and has outlined continued growth despite mix effects. Feedback suggests strategic initiatives and innovation, including AI‑enabled offerings, are helping sustain demand.

Investor Backing & Capital Strength: Funding announcements cite a $70M Series C in May 2025 with participation from prominent firms, indicating strong capital available for scaling. Third-party trackers also reflect this round, reinforcing available runway.

Innovation-Driven Growth: Public updates show a rapid release cadence through 2025–2026—agents, integrations, developer tools, and AI-focused features—that expand the platform’s surface area. This sustained shipping suggests momentum driven by product innovation.

Market Expansion: Company materials note “over 1,500 teams” by mid-2025 and describe “millions” of monthly data tasks across companies from startups to Fortune 500s, pointing to broadening engagement. Ongoing hiring across functions in 2026 aligns with serving a growing user base.

Strong Revenue Growth: Recent results show FY2026 total revenue rose 19% year over year to about $2.02B, with Q4 revenue up 19% to roughly $532M. ARR ended FY2026 near $2.05B with a fourth consecutive quarter of mid‑teens constant‑currency growth and FY2027 guidance implying continued expansion.

Healthy Cash Flow: FY2026 free cash flow was reported at approximately $529M, reflecting strong cash generation alongside the subscription-heavy model. The company also cited robust full‑year free cash flow margins, underscoring financial stability.

Product Line Growth: Log management was cited as the fastest‑growing major product in Q4, with consumption more than doubling year over year. Recent acquisitions such as Bindplane and DevCycle expand telemetry pipelines and feature management, broadening the platform’s growth vectors.

Market Expansion: Feedback suggests the completed acquisition of Urgently and recent collaborations (e.g., KeyMe, Virginia Farm Bureau Insurance) expand technology, client reach, and service capacity. Continued emphasis on managing 13–14 million annual events and coverage for roughly 150 million drivers supports a scaling footprint.

Strong Market Position & Advantage: Available information indicates Agero was named Frost & Sullivan’s 2025 North American Company of the Year for digitalized roadside assistance, a signal of execution and momentum. Scale metrics repeatedly cited in 2026 materials reinforce leadership within white‑label roadside services.

Innovation-Driven Growth: Feedback suggests product and platform advances (e.g., Crash Response growth, Swoop capabilities, GenAI/automation recognition) are contributing to expansion. Post‑close plans to combine Swoop and Urgently capabilities point to continued tech‑led growth.

Investor Backing & Capital Strength: Recent funding trackers indicate a fresh 2025 round of about $26.35M, bringing total capital raised to roughly $76M—providing fuel to scale product and go‑to‑market.

Market Expansion: Multiple 2025–2026 manufacturer and distributor notices show transitions to Truzo (e.g., Alkermes, Organon, Gilead via Cencora). These migrations suggest growing adoption across stakeholders.

Product Line Growth: Kalderos promotes Truzo as an end‑to‑end drug discount management platform and continues to enhance solutions like Discount Hub and Commercial Discount Monitoring. Industry commentary and company materials highlight expanding capabilities aligned to today’s 340B environment.

Strong Hiring & Retention: Feedback suggests accelerating headcount growth from a few hundred in 2020 to about 1,700 by late 2023, alongside continued recruiting signals.

Market Expansion: Evidence points to expanding the India GCC’s physical footprint and scope, including larger office space and added global functions like procurement and FP&A.

Future-Ready Strategy: Statements emphasize digital transformation focus across application development, cloud, data science, and analytics, positioning the GCC as a strategic extension of the parent.

Strong Revenue Growth: Public filings and coverage describe revenue increasing from 2024 into 2025, with sequential core advertising gains and a larger trailing twelve‑month run rate. Multiple summaries cite continued top‑line expansion through late 2025.

Investor Backing & Capital Strength: A May 2025 minority investment by General Atlantic at a multi‑billion valuation, with Blackstone remaining majority owner, signals external confidence and access to capital. Active IPO filings and refilings in 2026 further indicate readiness to tap public markets.

Strong Market Position & Advantage: Third‑party indices (e.g., AppsFlyer, Singular) note numerous top‑tier placements, and the platform reports broad SDK reach and global advertiser usage. The 2021 Liftoff–Vungle combination expanded scale across user acquisition and monetization, reinforcing competitive standing.

Product Line Growth: Recent posts cite platform updates like the NextGen Processing Engine and Search Hit Reports with release dates of December 15, 2025 and January 15, 2026. Continued feature releases indicate ongoing investment in the core product.

Strategic Partnerships: A strategic partnership with The Chicago Bar Association was announced in May/June 2025, signaling a channel-oriented approach to customer acquisition. Such alliances can expand distribution and accelerate go-to-market.

Investor Backing & Capital Strength: In July 2023, the company received a growth capital investment from RF Investment Partners. The stated use of funds was to accelerate market expansion, operational advancements, and product development.

Investor Backing & Capital Strength: A large Series D round in February 2026 led by a top-tier investor at a unicorn valuation signals strong capital support. The new funding is described as runway for headcount, product development, and market expansion.

Strong Revenue Growth: Company communications around the 2026 financing cite rapid year-over-year revenue gains. This momentum is positioned as evidence of increasing commercial adoption.

Market Expansion: Public materials reference a growing base of hundreds of organizations and new health-system partnerships announced in 2026. Ongoing hiring and new launches in May 2026 indicate active go-to-market execution.

Investor Backing & Capital Strength: Recent investment from Blackstone Growth of $100 million, with media reporting an approximately $700 million valuation and independent confirmation by Simpson Thacher, signals strong external support to scale. Feedback suggests this late-stage capital represents a step up from earlier, smaller raises, strengthening financing capacity.

Market Expansion: Company materials and case studies describe deployments across corporate communications, public affairs, investor relations, and crisis communications for large enterprises. Feedback suggests this expanding set of use cases indicates broader adoption that can translate into revenue growth.

Strong Hiring & Retention: LinkedIn updates show ongoing senior hires and Built In’s 2026 Best Places to Work recognition for New York and DC offices, pointing to active recruitment and employer‑brand momentum. Feedback suggests sustained increases in headcount and senior go‑to‑market roles would reinforce a scale‑up trajectory.

Investor Backing & Capital Strength: A recent majority investment by Vista Equity Partners at a higher valuation signals strong external confidence and resources to scale. The material step-up from the 2021 valuation indicates durable investor support for future growth.

Strong Market Position & Advantage: Consecutive Leader placements in Gartner’s Magic Quadrant (2024, 2025) and leadership recognition in Forrester’s 2024 EUEM Wave underscore sustained competitive strength. Such analyst validations typically align with strong execution and visibility in the category.

Product Line Growth: The acquisition of AppLearn in 2024 extends capabilities from endpoint telemetry into digital adoption, broadening the end‑to‑end DEX offering. Subsequent productization (e.g., Adopt on Infinity) indicates an expanding portfolio aligned to adjacent use cases.

Strong Revenue Growth: Company announcements describe breakout ARR growth in 2025 driven by new and expanding relationships with private‑equity sponsors and their portfolio companies. This is the clearest revenue momentum indicator the company has published.

Market Expansion: A sizable Chicago office lease and stated plans to materially increase local headcount, plus recent New York and Dallas moves, indicate geographic scaling. Active recruiting and multiple listed offices reinforce an expanding footprint.

Product Line Growth: The company’s news flow shows ongoing platform and product additions across 2025–2026, including a pricing suite and the Astradis launch. Such releases are consistent with a scaling go‑to‑market.